Our observation that suppression of p53 in breast cancer cells promotes chemotaxis towards CXCL13 gradient, harmonizes with other p53 anticancer effects and fits the classical model of metastasis which involves immune cells that prepare tumor microenvironment for cancer cell migration39. Here, CXCL13 is linked to breast cancer.